In one aspect, the present disclosure is directed to a topical antimicrobial composition, including: a lipophilic component including a surfactant system with an HLB value of less than 10; an amphiphilic component including an antimicrobial compound; and an aqueous hydrophilic component. The composition includes less than 10 wt % of lower monohydric alcohols, based on the total weight of the composition, and is in the form of a microemulsion at room temperature with a disperse phase having droplets with a particle size of 5 nm to 400 nm.

In one aspect, the present disclosure is directed to a topical antimicrobial composition, including: a lipophilic component including a surfactant system with an HLB value of less than 10; an amphiphilic component including an antimicrobial compound; and an aqueous hydrophilic component. The composition includes less than 10 wt % of lower monohydric alcohols, based on the total weight of the composition, and is in the form of a microemulsion at room temperature with a disperse phase having droplets with a particle size of 5 nm to 400 nm.

A topical antimicrobial composition includes a lipophilic component including a surfactant system with an HLB value of less than 10; an amphiphilic component including an antimicrobial compound; an aqueous hydrophilic component; and a fluorescent material. The composition includes less than 10 wt % of lower monohydric alcohols based on the total weight of the composition. The composition is in the form of a microemulsion at room temperature with a disperse phase having droplets with a particle size of 5 nm to 400 nm.

The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.

The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.

Present invention relates to a process for permanent waving keratin fibers, especially human hair, for achieving durable waves wherein fibers are treated with a reducing composition, a non-reducing and non-oxidizing alkaline composition, a non-reducing and non-oxidizing acidic composition and finally an oxidizing composition wherein after processing the reducing composition the fibers are rinsed off.

An object of the present invention is to provide a composition that can be used as a novel anti-inflammatory agent. An inflammation such as stomatitis, oral mucositis, gingivitis, or pneumonia can be ameliorated and/or prevented by using a composition comprising olanexidine or a pharmacologically acceptable salt thereof. The composition of the present invention preferably further comprises a poloxamer which is a block copolymer consisting of a chain of polyoxypropylene (POP) and two chains of polyoxyethylene (POE) flanking the POP.

Therapeutic compositions, primarily for topical application, and methods of making and using the composition. Pharmaceutical compositions formulated for specific forms of administration are also provided.

Therapeutic compositions, primarily for topical application, and methods of making and using the composition. Pharmaceutical compositions formulated for specific forms of administration are also provided.

Novel tris-substituted biguanide compounds are made by reaction of sodium dicyanamide with a trifunctional primary amine followed by reaction with anilines. The tris-substituted biguanide compounds are potent biocide and useful as a disinfectant. The novel compounds have biocidal activity comparable to those of widely used chlorhexidine with respect to width of antibacterial spectrum and in immediate effectiveness. The novel tris-substituted biguanide compounds can also be used for cleaning wounds, preventing dental plaque, treating yeast infections of the mouth, and to keep urinary catheters from blocking, These novel compounds have superior aqueous solubility and bioavailability and have potent antibacterial activity especially against A. baumanni and K. pneumonia.